Galaxia M Rodriguez
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 12, 2025
Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression.Yalun Zhu, Atefeh Abedini, Galaxia M Rodriguez
|Mar 10, 2025
Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer.Alison O Cudmore, Galaxia M Rodriguez, Vincent Maranda
|Dec 09, 2023
Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.Galaxia M Rodriguez, Edward Yakubovich, Barbara C Vanderhyden
|Aug 26, 2023
Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential.Jordan D Lewicky, Alexandrine L Martel, Mukul Raj Gupta
|Jul 28, 2018
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics.Curtis W McCloskey, Galaxia M Rodriguez, Kristianne J C Galpin
|Jul 26, 2018
The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy.Galaxia M Rodriguez, Kristianne J C Galpin, Curtis W McCloskey
Pageof 1
Frequent Collaborators
6 joint publications
Barbara Vanderhyden
2 joint publications
Kristianne J C Galpin
2 joint publications
Curtis W McCloskey
1 joint publications
Alexandrine L Martel
1 joint publications
René Roy
1 joint publications
Hoang-Thanh Le
1 joint publications
Edward Yakubovich
1 joint publications
Alison O Cudmore
1 joint publications
Vincent Maranda
1 joint publications
Salar Farokhi Boroujeni
